Literature DB >> 9365456

Losartan-associated atypical cutaneous lymphoid hyperplasia.

R Viraben, L Lamant, P Brousset.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9365456     DOI： 10.1016/S0140-6736(05)65136-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Comparative safety and tolerability of angiotensin II receptor antagonists.

Authors:  L Mazzolai; M Burnier
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

2.  Clinical and Histopathological Characteristics of Cutaneous Lymphoid Hyperplasia: A Comparative Study According to Causative Factors.

Authors:  Myoung Eun Choi; Keon Hee Lee; Dong Jun Lim; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Woo Jin Lee
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

3.  Severe acute interstitial nephritis induced by valsartan: A case report.

Authors:  Tong Chen; Peng-Cheng Xu; Shui-Yi Hu; Tie-Kun Yan; Jian-Qing Jiang; Jun-Ya Jia; Li Wei; Wen-Ya Shang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

4.  Multifocal and recurrent cutaneous pseudolymphoma associated with lamotrigine and review of the literature.

Authors:  Soroush Kazemi; Elanee Simmons; Maija Kiuru; Danielle M Tartar
Journal:  JAAD Case Rep       Date:  2022-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.